<p>Dead cells were excluded with a viability stain before gating on CD45+ cells. CD45+ cells were further analyzed for CD3+ and CD14+ expression. CD45+CD3+ cells were gated on CD4+ or CD8+ before HLA-DR/CD38 quadrant gating as well as CCR5 co-receptor expression. CD45+CD14+ cells were also analyzed for CCR5 expression.</p
<p>Stained PBMC were gated on cells with high FSC and SSC characteristics avoiding the lymphocyte re...
<p>Monocytes were defined as CD45 and HLA-DR expressing and lineage (CD2, CD3, CD15, CD19, CD56, NKp...
(A) For panel 6, the strategies of the first to fourth gates were the same as panel 4 (Fig 4). After...
<p>The gating strategy applied for mucosal mononuclear cells (MMC) and peripheral blood mononuclear ...
<p>Monocytes were defined as CD45 positive cells (B) exhibiting a typical forward (FSC) and sideward...
<p>(A) Monocytes (CD14<sup>+</sup>), B cells (CD19<sup>+</sup>) were gated from PBMC. pDC were direc...
After primary gating for CD45, various cell subsets were gated as shown and percentage values for ea...
<p>(A) After gating for single cells in forward scatter area (FSC-A) versus height (FSC-H) and side ...
<p>CD4 and CD8 memory (CD45RO+/CD45RA<sup>neg</sup>) and naïve (CD45RO<sup>neg</sup>/CD45RA+) T cell...
<p><b>A.</b> PBMC and <b>B.</b> MBC. Initial gating is performed from the SSC-A vs. FSC-A to determi...
<p>Total CD45+ cells were gated, followed by Side Scatter (SS) <i>vs</i> CD34-FITC. The CD34+CD45+SS...
<p>Monocytes were first selected on the basis of their physical parameters, i.e. forward scatter (FS...
Shown are gating strategies for the analysis of (A), human immune cell subsets (hCD45+CD3+: T cells,...
<p>These plots represent the gating strategy used for flowcytometry analysis of blood samples; lymph...
<p>Dead cells were excluded by selecting all live cells from the forward/side scatter plot (A), afte...
<p>Stained PBMC were gated on cells with high FSC and SSC characteristics avoiding the lymphocyte re...
<p>Monocytes were defined as CD45 and HLA-DR expressing and lineage (CD2, CD3, CD15, CD19, CD56, NKp...
(A) For panel 6, the strategies of the first to fourth gates were the same as panel 4 (Fig 4). After...
<p>The gating strategy applied for mucosal mononuclear cells (MMC) and peripheral blood mononuclear ...
<p>Monocytes were defined as CD45 positive cells (B) exhibiting a typical forward (FSC) and sideward...
<p>(A) Monocytes (CD14<sup>+</sup>), B cells (CD19<sup>+</sup>) were gated from PBMC. pDC were direc...
After primary gating for CD45, various cell subsets were gated as shown and percentage values for ea...
<p>(A) After gating for single cells in forward scatter area (FSC-A) versus height (FSC-H) and side ...
<p>CD4 and CD8 memory (CD45RO+/CD45RA<sup>neg</sup>) and naïve (CD45RO<sup>neg</sup>/CD45RA+) T cell...
<p><b>A.</b> PBMC and <b>B.</b> MBC. Initial gating is performed from the SSC-A vs. FSC-A to determi...
<p>Total CD45+ cells were gated, followed by Side Scatter (SS) <i>vs</i> CD34-FITC. The CD34+CD45+SS...
<p>Monocytes were first selected on the basis of their physical parameters, i.e. forward scatter (FS...
Shown are gating strategies for the analysis of (A), human immune cell subsets (hCD45+CD3+: T cells,...
<p>These plots represent the gating strategy used for flowcytometry analysis of blood samples; lymph...
<p>Dead cells were excluded by selecting all live cells from the forward/side scatter plot (A), afte...
<p>Stained PBMC were gated on cells with high FSC and SSC characteristics avoiding the lymphocyte re...
<p>Monocytes were defined as CD45 and HLA-DR expressing and lineage (CD2, CD3, CD15, CD19, CD56, NKp...
(A) For panel 6, the strategies of the first to fourth gates were the same as panel 4 (Fig 4). After...